FDA guidance updates postmarket surveillance program

08/18/2011 | MassDevice.com (Boston)

The FDA has issued guidance outlining the types of devices that may be eligible for postmarket surveillance as well as how manufacturers should comply with the program. The guidance, which will be up for comment over the next three months, also recommends that the 36-month surveillance period be extended for pediatric devices.

View Full Article in:

MassDevice.com (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC